Literature DB >> 2475197

Benign prostatic hyperplasia: the best treatment.

G D Chisholm1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2475197      PMCID： PMC1836932          DOI： 10.1136/bmj.299.6693.215

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  23 in total

1.  II. The Question of Castration for Enlarged Prostate.

Authors:  A T Cabot
Journal:  Ann Surg       Date:  1896-09       Impact factor: 12.969

2.  Prazosin in the treatment of prostatic obstruction. A placebo-controlled study.

Authors:  R S Kirby; S W Coppinger; M O Corcoran; C R Chapple; M Flannigan; E J Milroy
Journal:  Br J Urol       Date:  1987-08

3.  Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.

Authors:  N P Roos; J E Wennberg; D J Malenka; E S Fisher; K McPherson; T F Andersen; M M Cohen; E Ramsey
Journal:  N Engl J Med       Date:  1989-04-27       Impact factor: 91.245

4.  Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.

Authors:  P C Walsh; J D Madden; M J Harrod; J L Goldstein; P C MacDonald; J D Wilson
Journal:  N Engl J Med       Date:  1974-10-31       Impact factor: 91.245

5.  A double-blind, controlled, clinical trial of spironolactone for benign prostatic hypertrophy.

Authors:  J E Castro; H J Griffiths; D E Edwards
Journal:  Br J Surg       Date:  1971-07       Impact factor: 6.939

6.  A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction.

Authors:  M Caine; S Perlberg; S Meretyk
Journal:  Br J Urol       Date:  1978-12

7.  The natural history of untreated "prostatism".

Authors:  A J Ball; R C Feneley; P H Abrams
Journal:  Br J Urol       Date:  1981-12

8.  Effects of prazosin in patients with benign prostatic obstruction.

Authors:  H Hedlund; K E Andersson; A Ek
Journal:  J Urol       Date:  1983-08       Impact factor: 7.450

9.  Aromatase inhibition in the dog. II. Effect on growth, function, and pathology of the prostate.

Authors:  J E Oesterling; P E Juniewicz; J R Walters; J D Strandberg; R E Steele; L L Ewing; D S Coffey
Journal:  J Urol       Date:  1988-04       Impact factor: 7.450

10.  Balloon dilatation of the prostate for treatment of benign hyperplasia.

Authors:  P K Reddy; N Wasserman; F Castañeda; W R Castañeda-Zuñiga
Journal:  Urol Clin North Am       Date:  1988-08       Impact factor: 2.241
View more
  9 in total

1.  Length of postoperative hospital stay after transurethral resection of the prostate.

Authors:  M M Kirollos
Journal:  Ann R Coll Surg Engl       Date:  1997-07       Impact factor: 1.891

2.  The significance of histological analysis following laser transurethral resection of the prostate.

Authors:  Shady Nafie; John Dormer; Masood A Khan
Journal:  Int Urol Nephrol       Date:  2017-05-15       Impact factor: 2.370

Review 3.  Comparison of the cost-effectiveness of various therapies for common prostatic disorders.

Authors:  E A Amin; M Amin
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

4.  Treatment of benign prostatic hyperplasia.

Authors:  K McPherson
Journal:  BMJ       Date:  1989-09-16

Review 5.  Benign prostatic hyperplasia.

Authors:  R J Simpson
Journal:  Br J Gen Pract       Date:  1997-04       Impact factor: 5.386

6.  The Cochrane Lecture. The best and the enemy of the good: randomised controlled trials, uncertainty, and assessing the role of patient choice in medical decision making.

Authors:  K McPherson
Journal:  J Epidemiol Community Health       Date:  1994-02       Impact factor: 3.710

7.  Estimation of irrigant absorption during transurethral resection of the prostate. Assessment of fluorescein as a marker.

Authors:  D A Bender; S W Coppinger
Journal:  Urol Res       Date:  1992

8.  Who should have a prostatectomy? A survey of the management of patients presenting with bladder outflow obstruction.

Authors:  S N Lloyd; D Kirk
Journal:  J R Soc Med       Date:  1991-09       Impact factor: 18.000

9.  Use of oral tramadol to prevent perianesthetic shivering in patients undergoing transurethral resection of prostate under subarachnoid blockade.

Authors:  Anurag Tewari; Ira Dhawan; Vidhi Mahendru; Sunil Katyal; Avtar Singh; Shuchita Garg
Journal:  Saudi J Anaesth       Date:  2014-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.